Toronto Dominion Bank’s Novo Nordisk NVO Stock Holding History

Toronto Dominion Bank’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.15K	Sell	86 -15,962	-99%	-$756K	﹤0.01%	1991
2025 Q4	$816K	Sell	16,048 -161	-1%	-$8.23K	﹤0.01%	1298
2025 Q3	$900K	Sell	16,209 -7,478	-32%	-$438K	﹤0.01%	1202
2025 Q2	$1.64M	Buy	23,687 +5,907	+33%	+$402K	﹤0.01%	1019
2025 Q1	$1.23M	Sell	17,780 -14,415	-45%	-$1.19M	﹤0.01%	1041
2024 Q4	$2.77M	Buy	32,195 +17,332	+117%	+$1.87M	﹤0.01%	844
2024 Q3	$1.77M	Sell	14,863 -19,858	-57%	-$2.65M	﹤0.01%	782
2024 Q2	$4.96M	Sell	34,721 -1,857	-5%	-$246K	0.01%	640
2024 Q1	$4.7M	Sell	36,578 -9,011	-20%	-$1.07M	0.01%	648
2023 Q4	$4.72M	Sell	45,589 -323	-0.7%	-$31.9K	0.01%	707
2023 Q3	$4.18M	Sell	45,912 -1,582	-3%	-$139K	0.01%	729
2023 Q2	$3.84M	Sell	47,494 -10,020	-17%	-$819K	0.01%	765
2023 Q1	$4.58M	Sell	57,514 -18	-0%	-$1.28K	0.01%	703
2022 Q4	$3.9M	Sell	57,532 -3,916	-6%	-$230K	0.01%	743
2022 Q3	$3.04M	Hold	61,448	–	–	0.01%	779
2022 Q2	$3.43M	Sell	61,448 -1,316	-2%	-$73K	0.01%	638
2022 Q1	$3.49M	Sell	62,764 -2,698	-4%	-$138K	0.01%	664
2021 Q4	$3.66M	Sell	65,462 -7,324	-10%	-$397K	﹤0.01%	696
2021 Q3	$3.5M	Buy	72,786 +264	+0.4%	+$12.8K	0.01%	653
2021 Q2	$3.03M	Sell	72,522 -2,420	-3%	-$93.8K	﹤0.01%	668
2021 Q1	$2.53M	Sell	74,942 -2,420	-3%	-$86.2K	﹤0.01%	692
2020 Q4	$2.7M	Sell	77,362 -1,094	-1%	-$37.8K	0.01%	724
2020 Q3	$2.73M	Buy	78,456 +14,934	+24%	+$498K	0.01%	667
2020 Q2	$2.09M	Buy	63,522 +7,244	+13%	+$231K	0.01%	722
2020 Q1	$1.71M	Sell	56,278 -3,110	-5%	-$92.6K	0.01%	672
2019 Q4	$1.72M	Sell	59,388 -7,858	-12%	-$218K	﹤0.01%	787
2019 Q3	$1.74M	Buy	67,246 +58,226	+646%	+$1.47M	﹤0.01%	863
2019 Q2	$115K	Sell	9,020 -54,746	-86%	-$1.35M	﹤0.01%	1131
2019 Q1	$1.67M	Sell	63,766 -6,696	-10%	-$165K	﹤0.01%	863
2018 Q4	$1.63M	Buy	70,462 +31,580	+81%	+$702K	﹤0.01%	811
2018 Q3	$918K	Buy	38,882 +2,400	+7%	+$58.6K	﹤0.01%	896
2018 Q2	$842K	Buy	36,482 +232	+0.6%	+$5.51K	﹤0.01%	941
2018 Q1	$892K	Sell	36,250 -1,056	-3%	-$27.7K	﹤0.01%	834
2017 Q4	$1M	Sell	37,306 -130	-0.3%	-$3.31K	﹤0.01%	762
2017 Q3	$903K	Hold	37,436	–	–	﹤0.01%	703
2017 Q2	$804K	Buy	37,436 +10,236	+38%	+$207K	﹤0.01%	728
2017 Q1	$468K	Hold	27,200	–	–	﹤0.01%	778
2016 Q4	$488K	Hold	27,200	–	–	﹤0.01%	754
2016 Q3	$567K	Buy	27,200 +5,600	+26%	+$139K	﹤0.01%	565
2016 Q2	$584K	Hold	21,600	–	–	﹤0.01%	416
2016 Q1	$583K	Sell	21,600 -12,934	-37%	-$347K	﹤0.01%	356
2015 Q4	$1.01M	Sell	34,534 -726	-2%	-$20.1K	0.01%	347
2015 Q3	$961K	Hold	35,260	–	–	0.01%	350
2015 Q2	$965K	Sell	35,260 -8,740	-20%	-$246K	﹤0.01%	393
2015 Q1	$1.17M	Sell	44,000 -1,312	-3%	-$30.2K	0.01%	342
2014 Q4	$957K	Buy	45,312 +12,400	+38%	+$277K	﹤0.01%	416
2014 Q3	$1M	Hold	32,912	–	–	﹤0.01%	362
2014 Q2	$759K	Hold	32,912	–	–	﹤0.01%	415
2014 Q1	$780K	Buy	32,912 +12,912	+65%	+$275K	﹤0.01%	395
2013 Q4	$369K	Sell	20,000 -3,600	-15%	-$62.7K	﹤0.01%	513
2013 Q3	$398K	Buy	23,600 +3,600	+18%	+$60.5K	﹤0.01%	415
2013 Q2	$311K	Buy	+20,000	New	+$333K	﹤0.01%	454

Other funds holding NVO

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Toronto Dominion Bank's NVO Position: Q1 2026 in Review

Toronto Dominion Bank reduced its Novo Nordisk (NVO) stake by 99% in Q1 2026, selling an estimated $756K and leaving 86 shares worth $3.15K. The position accounts for ﹤0.01% of the portfolio, ranked #1991.

Toronto Dominion Bank first reported a position in NVO in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.96M in Q2 2024. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

Toronto Dominion Bank held 86 shares of Novo Nordisk worth $3.15K as of Q1 2026.
Toronto Dominion Bank sold 15,962 Novo Nordisk shares in Q1 2026, an estimated $756K.
Novo Nordisk made up ﹤0.01% of Toronto Dominion Bank's portfolio in Q1 2026, its #1991 holding.
Toronto Dominion Bank first reported a position in Novo Nordisk in Q2 2013 and has held it in 52 quarters since.
Toronto Dominion Bank's Novo Nordisk position peaked at $4.96M in Q2 2024.
1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Toronto Dominion Bank's 13F filing for Q1 2026, filed 15 May 2026.